Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
Schmitz, S., Kaminsky-Forrett, M.-C., Henry, S., Zanetta, S., Geoffrois, L., Bompas, E., Moxhon, A., Mignion, L., Guigay, J., Knoops, L., Hamoir, M., Machiels, J.-P.
Published in Annals of oncology (01.08.2012)
Published in Annals of oncology (01.08.2012)
Get full text
Journal Article
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02
Schmitz, S., Kaminsky-Forrett, M., Henry, S., Zanetta, S., Geoffrois, L., Bompas, E., Moxhon, A., Guigay, J., Machiels, J. H.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase I study of sorafenib in association with docetaxel-prednisone in chemonaive metastatic castration-resistant prostate cancer
Mardjuadi, F., Medioni, J., Kerger, J., Canon, J. L., Duck, L., Oudard, S., Clausse, M., D'Hondt, L., Moxhon, A., Machiels, J. P.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study
Van Cangh, P J, Richard, F, Lorge, F, Castille, Y, Moxhon, A, Opsomer, R, De Visscher, L, Wese, F X, Scaillet, P
Published in The Journal of urology (01.01.1998)
Published in The Journal of urology (01.01.1998)
Get more information
Journal Article
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
Schmitz, S, Kaminsky-Forrett, M-C, Henry, S, Zanetta, S, Geoffrois, L, Bompas, E, Moxhon, A, Mignion, L, Guigay, J, Knoops, L, Hamoir, M, Machiels, J-P
Published in Annals of oncology (01.08.2012)
Get full text
Published in Annals of oncology (01.08.2012)
Journal Article
A randomized phase II study comparing tolerance and efficacy of goserelin (‘Zoladex’) alone or combined with raltitrexed (‘Tomudex’), in high-risk advanced prostate cancer (PCa): preliminary results on tolerance
Tombal, B., Machiels, J., Moxhon, A., Van Cangh, P., Humblet, Y.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article